These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16301302)

  • 1. Antibiotic therapy and outcome in critically ill patients with pneumococcal bacteremia.
    Depuydt P; Benoit D; Vandewoude K; Decruyenaere J
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1472; author reply 1474. PubMed ID: 16301302
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential mechanisms for mortality reduction associated with combination antibiotic therapy among severely ill patients with pneumococcal bacteremia.
    Schwartz DN
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1472-3; author reply 1474. PubMed ID: 16301303
    [No Abstract]   [Full Text] [Related]  

  • 3. Is combination the only issue?
    Boussekey N; Faure K; Guery B
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1473-4; author reply 1474. PubMed ID: 16301304
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia.
    Baddour LM; Yu VL; Klugman KP; Feldman C; Ortqvist A; Rello J; Morris AJ; Luna CM; Snydman DR; Ko WC; Chedid MB; Hui DS; Andremont A; Chiou CC;
    Am J Respir Crit Care Med; 2004 Aug; 170(4):440-4. PubMed ID: 15184200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study.
    Kumar A; Safdar N; Kethireddy S; Chateau D
    Crit Care Med; 2010 Aug; 38(8):1651-64. PubMed ID: 20562695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for pneumococcal bacteremia: monotherapy or combination therapy?
    Feldman C; Anderson R
    Curr Opin Infect Dis; 2009 Apr; 22(2):137-42. PubMed ID: 19276880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy.
    Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I
    Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of pneumococcal bacteremia in adult patients with liver cirrhosis.
    Choi SH; Park HG; Jun JB; Lee SO; Choi SH; Woo JH; Kim YS
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):160-4. PubMed ID: 19150708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae.
    Cheng MP; Bogoch II; Green K; Plevneshi A; Rudnick W; Shigayeva A; McGeer A; Lee TC;
    Clin Infect Dis; 2018 Apr; 66(8):1282-1285. PubMed ID: 29140429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.
    Yu VL; Chiou CC; Feldman C; Ortqvist A; Rello J; Morris AJ; Baddour LM; Luna CM; Snydman DR; Ip M; Ko WC; Chedid MB; Andremont A; Klugman KP;
    Clin Infect Dis; 2003 Jul; 37(2):230-7. PubMed ID: 12856216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serious bacterial infection in children.
    Bergus G
    J Fam Pract; 1997 Jun; 44(6):531-2. PubMed ID: 9191620
    [No Abstract]   [Full Text] [Related]  

  • 12. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
    Bonnard P; Lescure FX; Douadi Y; Schmit JL; Jounieaux V; Laurans G; Eb F; Ducroix JP
    J Infect; 2005 Jul; 51(1):69-76. PubMed ID: 15979494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric antimicrobial therapy for Gram-negative sepsis: back to the future.
    Leekha S; Standiford HC
    Crit Care Med; 2011 Aug; 39(8):1995-6. PubMed ID: 21768802
    [No Abstract]   [Full Text] [Related]  

  • 14. Does antibiotic selection impact patient outcome?
    Harbarth S; Nobre V; Pittet D
    Clin Infect Dis; 2007 Jan; 44(1):87-93. PubMed ID: 17143822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
    Kelley MA; Weber DJ; Gilligan P; Cohen MS
    Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003-2009.
    Giner AM; Kuster SP; Zbinden R; Ruef C; Ledergerber B; Weber R
    Infection; 2011 Dec; 39(6):519-26. PubMed ID: 22065426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eleven-year study of recurrent pneumococcal bacteremia.
    Font B; Llimiñana C; Fontanals D; Pineda V; Segura F
    Eur J Clin Microbiol Infect Dis; 2001 Sep; 20(9):636-8. PubMed ID: 11714044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis.
    Vilay AM; Grio M; Depestel DD; Sowinski KM; Gao L; Heung M; Salama NN; Mueller BA
    Crit Care Med; 2011 Jan; 39(1):19-25. PubMed ID: 20890189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive blood cultures and diagnosis of bacterial meningitis in cases with negative culture of cerebrospinal fluid.
    Fuglsang-Damgaard D; Pedersen G; Schønheyder HC
    Scand J Infect Dis; 2008; 40(3):229-33. PubMed ID: 17907046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia.
    Loeffler JM; Djurkovic S; Fischetti VA
    Infect Immun; 2003 Nov; 71(11):6199-204. PubMed ID: 14573637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.